User profiles for Abhishek Gadre
Abhishek GadreUniversity of California San Diego Verified email at ucsd.edu Cited by 280 |
Cardiac implantable electronic device infections: added complexity and suboptimal outcomes with previously abandoned leads
Objectives : This study sought to assess the impact of previously abandoned leads on the
clinical management of cardiac device infections, notably transvenous lead extraction and …
clinical management of cardiac device infections, notably transvenous lead extraction and …
Counting steps: a new way to monitor patients with pulmonary arterial hypertension
Rationale Activity levels in patients with pulmonary arterial hypertension (PAH) have
correlated with surrogate markers of disease severity. It is not known whether physical activity …
correlated with surrogate markers of disease severity. It is not known whether physical activity …
Clinical characteristics and associated systemic diseases in patients with Esophageal “absent contractility”—a clinical algorithm
Background: The Chicago Classification version 3.0 has redefined major and minor esophageal
motility disorders using high-resolution esophageal manometry. There is a dearth of …
motility disorders using high-resolution esophageal manometry. There is a dearth of …
Six-minute walk test as a predictor of diagnosis, disease severity, and clinical outcomes in scleroderma-associated pulmonary hypertension: the DIBOSA study
Background Pulmonary hypertension (PH) is a common complication of scleroderma (SSc)
and is a leading cause of morbidity and mortality. Objectives To explore the utility of the …
and is a leading cause of morbidity and mortality. Objectives To explore the utility of the …
Hypersensitivity pneumonitis, allergic bronchopulmonary aspergillosis and other eosinophilic lung diseases
J Barry, A Gadre, P Akuthota - Current Opinion in Immunology, 2020 - Elsevier
Highlights • A high index of suspicion is key to the diagnosis of HP; antigen avoidance is the
definitive therapy. • Allergic bronchopulmonary aspergillosis (ABPA) should be considered …
definitive therapy. • Allergic bronchopulmonary aspergillosis (ABPA) should be considered …
Tranexamic acid for hemoptysis: a review
A Gadre, JK Stoller - Clinical Pulmonary Medicine, 2017 - journals.lww.com
Tranexamic acid (TXA) is an antifibrinolytic agent used to promote hemostasis. TXA is widely
used to arrest bleeding in trauma, perioperatively after cardiac surgery, for menorrhagia, …
used to arrest bleeding in trauma, perioperatively after cardiac surgery, for menorrhagia, …
Safety of catheter ablation for atrial fibrillation in patients with prior cerebrovascular events
Objectives : This study sought to report on the safety of catheter ablation for atrial fibrillation (AF)
in patients with prior cerebrovascular events (CVEs), at a large-volume tertiary care …
in patients with prior cerebrovascular events (CVEs), at a large-volume tertiary care …
[HTML][HTML] Reversible Platypnea–Orthodeoxia Syndrome from Ventilation–Perfusion Mismatch in Interstitial Lung Disease: A Novel Etiology
Discussion To the best of our knowledge, this is the first reported case in the English literature
of platypnea–orthodeoxia syndrome associated with antisynthetase syndrome. A similar …
of platypnea–orthodeoxia syndrome associated with antisynthetase syndrome. A similar …
[PDF][PDF] Descriptive analytical study looking for agreement between colposcopic cervical findings and cervical exfoliative cytology
Background: To see whether cervical findings on colposcopy & reports of exfoliative cytology
agree with each other according to grade of severity. Methods: This study included 306 …
agree with each other according to grade of severity. Methods: This study included 306 …
The Factor V Leiden variant and risk of chronic thromboembolic pulmonary hypertension
…, MM Cirulis, EL Wilson, A Gadre… - European …, 2020 - Eur Respiratory Soc
Chronic thromboembolic pulmonary hypertension (CTEPH) is a devastating complication that
occurs in about 3% of survivors of acute pulmonary embolism (PE) [1]. Genetic risk factors …
occurs in about 3% of survivors of acute pulmonary embolism (PE) [1]. Genetic risk factors …